| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |